Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 7, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| DXCM | DEXCOM INC | A | C | $23.12B | 390,016,272 | 94.16% | 4.61% | Net Selling | Net Selling |
| SGHC | SUPER GROUP (SGHC) LTD | A | B | $6.17B | 505,728,590 | 10.68% | 0.00% | ||
| GTES | GATES INDUSTRIAL CORP PLC | A | C | $5.64B | 258,280,391 | 89.38% | 10.62% | Net Buying | |
| TGTX | TG THERAPEUTICS INC | A | B | $5.40B | 158,665,613 | 56.43% | 43.57% | Net Selling | Net Selling |
| SEE | SEALED AIR CORP | A | B | $5.38B | 147,123,218 | 91.40% | 8.60% | Net Selling | Net Selling |
| MMSI | MERIT MEDICAL SYSTEMS INC | A | A | $5.16B | 59,290,248 | 95.09% | 4.91% | Net Selling | Net Buying |
| RSI | RUSH STREET INTERACTIVE INC | A | B | $3.81B | 229,412,772 | 25.77% | 74.23% | Net Selling | Net Selling |
| MIRM | MIRUM PHARMACEUTICALS INC | A | B | $3.52B | 50,237,647 | 51.49% | 48.51% | Net Selling | Net Buying |
| EXTR | EXTREME NETWORKS INC | A | C | $2.36B | 133,718,479 | 82.22% | 17.78% | Net Selling | Net Selling |
| SPNT | SIRIUSPOINT LTD | A | A | $2.27B | 116,814,640 | 64.49% | 35.51% | Net Selling | Net Buying |
| IHS | IHS HOLDING LTD | A | C | $2.22B | 335,521,000 | 37.71% | 0.00% | ||
| ARDT | ARDENT HEALTH INC | A | C | $2.10B | 143,106,447 | 46.26% | 53.74% | Net Selling | Net Selling |
| NTCT | NETSCOUT SYSTEMS INC | A | B | $1.95B | 71,328,733 | 77.58% | 22.42% | Net Selling | Net Selling |
| FIVN | FIVE9 INC | A | B | $1.76B | 77,262,690 | 71.92% | 28.08% | Net Selling | Net Selling |
| BLBD | BLUE BIRD CORP | A | C | $1.63B | 31,707,943 | 68.07% | 31.93% | Net Selling | Net Selling |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | A | $1.51B | 209,920,430 | 84.08% | 15.92% | Net Selling | Net Buying |
| DCO | DUCOMMUN INC | A | C | $1.37B | 14,877,749 | 88.44% | 10.45% | Net Selling | Net Selling |
| CRTO | CRITEO SA | A | B | $1.17B | 52,549,158 | 87.82% | 11.64% | Net Selling | Net Buying |
| ANAB | ANAPTYSBIO INC | A | B | $996.78M | 27,688,470 | 46.37% | 53.63% | Net Buying | Net Selling |
| EVER | EVERQUOTE INC | A | B | $898.54M | 35,955,921 | 59.18% | 40.82% | Net Selling | Net Selling |
| NRDS | NERDWALLET INC | A | C | $897.13M | 74,512,609 | 36.70% | 47.28% | Net Selling | Net Selling |
| UDMY | UDEMY INC | A | A | $778.72M | 146,376,765 | 56.19% | 43.81% | Net Selling | Net Selling |
| TBPH | THERAVANCE BIOPHARMA INC | A | C | $752.90M | 50,361,296 | 51.78% | 48.22% | Net Selling | Net Selling |
| AKBA | AKEBIA THERAPEUTICS INC | A | A | $556.79M | 262,635,836 | 41.23% | 7.72% | Net Selling | |
| EGHT | 8X8 INC | A | B | $300.01M | 136,368,843 | 69.88% | 30.12% | Net Selling | Net Selling |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | B | $249.19M | 17,635,552 | 21.91% | 78.09% | Net Selling | Net Buying |
| ELMD | ELECTROMED INC | A | B | $210.90M | 8,349,176 | 31.12% | 68.88% | Net Selling | Net Selling |
| INFU | INFUSYSTEM HOLDINGS INC | A | A | $203.36M | 20,336,183 | 25.39% | 74.61% | Net Selling | Net Selling |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.